Journal Guide

JAAD Case Reports® is an open access journal dedicated to publishing case reports. Manuscripts must be authentic, understandable, educational, and of interest to an international audience of dermatologists, residents, fellows, and researchers in all dermatology subspecialties, as well as clinicians in related fields. All submissions are peer reviewed. If accepted for publication, authors are requested to pay an article processing fee per article. Following payment of this fee, the article will be made universally available at www.sciencedirect.com and on Elsevier's HealthAdvance platform.

JACC: Advances provides a global forum for clinical research articles and timely reviews focused on advances in cardiovascular medicine. As an Open Access journal, its content is freely available, accelerating the translation of strong science into effective practice.

The Journal considers a broad range of original research articles, including applied clinical, epidemiological, and health care policy papers related to cardiovascular and cerebrovascular diseases. It strives to appeal to authors across the spectrum of the cardiovascular care team at every career stage.

Specific content areas of interest are as follows: arrhythmia and electrophysiology, cardio-obstetrics, cardiovascular surgery, congenital heart disease, coronary heart disease, critical care cardiology, digital health and health technology, genetics and genomics, geriatric cardiology, global health, health services and outcomes research, heart failure, cardiac imaging, interventional cardiology, molecular cardiology, neurocardiology, pediatric cardiology, preventative cardiology, sports cardiology, valvular heart disease, vascular medicine and emerging fields in cardiovascular medicine.

JACC: Cardiovascular Interventions encompasses the entire field of interventional cardiovascular medicine, including cardiac (coronary and non-coronary) peripheral and cerebrovascular interventions. JACC: Cardiovascular Interventions publishes studies that will impact the practice of interventional cardiovascular medicine including:• Clinical trials that provide evidence to inform and alter practice guidelines • Experimental studies that point to improved technologies and mechanistic understanding • In-depth discussions of topics of interest by respected experts in the field.Since interventional cardiovascular medicine is a highly visual specialty, the print journal is augmented by electronic publication allowing the latest technologies to be employed.Benefits to authorsWe also provide many author benefits, such as a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

JACC: Clinical Electrophysiology will encompass all aspects of the epidemiology, pathogenesis, diagnosis and treatment of cardiac arrhythmias. Submissions of original research and state-of-the-art reviews from cardiology, cardiovascular surgery, neurology, outcomes research, and related fields are encouraged. Experimental and preclinical work that directly relates to diagnostic or therapeutic interventions are also encouraged. In general, case reports will not be considered for publication.

JACC: Heart Failure publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical outcomes, and advances in therapies through timely, insightful scientific communication. The Journal embraces interdisciplinary relationships with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery as they relate to heart failure. In addition, the Journal includes articles concerning pharmacogenetics, biomarkers, and metabolomics.

JACS Au is a monthly open access multi-disciplinary journal devoted to the publication of manuscripts reporting significant research discoveries in all fields of chemistry. The journal considers submissions in traditional core fields including, but not limited to:

• Analytical, physical, inorganic, and organic chemistry
• Biological, medicinal, and environmental chemistry
• Computational and theoretical chemistry
• Materials and nanoscience
• Energy and catalysis
• Chemical engineering
• Chemical education
• Multidisciplinary research as it applies to chemistry

JACS Au considers submissions that are fully computational, fully experimental, and submissions that combine both

• Transcription and regulation
• Stem cell biology
• Cell death, growth and development
• Endocrinology and cellular metabolism
• Cardiovascular biology, neuroscience biology
• Infection and immunity, viral diseases
• Cancer biology

• Research papers/Reports
• Perspectives/Reviews
• Invited Special Focus topics
• Commentaries

JAK-STAT offers  online manuscript submission and peer-review by independent, anonymous expert referees, as well as a flexible open access policy. It is available in an online format.

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.